Literature DB >> 10886340

Cellular mechanisms of hyperalgesia and spontaneous pain in a spinalized rat model of peripheral neuropathy: changes in myelinated afferent inputs implicated.

G M Pitcher1, J L Henry.   

Abstract

Various hypotheses have been proposed to account for the mechanical hyperalgesia and spontaneous pain seen in animal models of peripheral neuropathy. The purpose of the present study was to determine whether there exists a spinal neuronal correlate to these properties. An experimental neuropathy was induced in male Sprague-Dawley rats by placing a 2-mm PE-90 polyethylene cuff around the sciatic nerve. All rats were subsequently confirmed to exhibit mechanical allodynia in the von Frey test. After induction of anaesthesia with pentobarbital and acute spinalization at T9, electrophysiological experiments were performed, recording extracellular single unit activity from ipsi- and contralateral wide dynamic range dorsal horn neurons in spinal segments L1-4. On-going activity was greater in short-term (11-22 days after cuff implantation) and long-term (42-52 days) cuff-implanted rats; 38 spikes/s in short-term versus 19 spikes/s in controls; 29 spikes/s in long-term ipsi- and contralateral neurons. Receptive fields in controls were always restricted, but in almost all cuff-implanted rats extended over the whole hind paw. Responses to noxious mechanical (pinch) and noxious heat stimulation of the cutaneous receptive field in controls consisted of the typical fast initial discharge followed by an afterdischarge. In all neurons from cuff-implanted rats the initial discharge resembled that in controls. However, the afterdischarge, particularly that in response to noxious pinch, was markedly greater in both magnitude and duration. It is suggested that the greater on-going discharge is the cellular correlate of spontaneous pain, and the potentiation of the afterdischarge in response to noxious stimulation is the correlate of hyperalgesia. Given that acutely spinalized rats were tested, only peripheral and/or spinal mechanisms can be considered to explain these data. Considering all the data, it can be concluded that there is a greater change in fibres mediating noxious mechanical than noxious thermal inputs. Among different hypotheses, the one with which the present data are most compatible is that which proposes that chronic nerve injury or inflammation induces phenotypic changes predominantly in myelinated afferents. There may be a redistribution of membrane-bound ion channels, predominantly sodium channels, which leads to ectopic activity and thus spontaneous discharge of dorsal horn neurons. With regard to mechanical stimulation-evoked synaptic input, the central terminals of myelinated afferents expand into regions of the spinal cord which normally receive their predominant input from unmyelinated nociceptive afferents. This may be coupled with a change in these myelinated afferents so that they now synthesize and release peptides, primarily substance P, from their central terminals with the result that the effects of their chemical mediators of synaptic transmission add to the effects of nociceptive inputs leading to exaggerated responses to painful stimuli, thus the basis of clinical hyperalgesia.

Entities:  

Mesh:

Year:  2000        PMID: 10886340     DOI: 10.1046/j.1460-9568.2000.00087.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  17 in total

1.  Alteration in the voltage dependence of NMDA receptor channels in rat dorsal horn neurones following peripheral inflammation.

Authors:  H Guo; L Y Huang
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

2.  Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain.

Authors:  Petr Dubový; I Klusáková; I Svízenská; V Brázda
Journal:  Histochem Cell Biol       Date:  2010-02-03       Impact factor: 4.304

3.  Spinal cord injury causes plasticity in a subpopulation of lamina I GABAergic interneurons.

Authors:  Kimberly J Dougherty; Shawn Hochman
Journal:  J Neurophysiol       Date:  2008-05-14       Impact factor: 2.714

4.  The kinin B1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance.

Authors:  J P Dias; M A Ismael; M Pilon; J de Champlain; B Ferrari; P Carayon; R Couture
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

5.  Governing role of primary afferent drive in increased excitation of spinal nociceptive neurons in a model of sciatic neuropathy.

Authors:  Graham M Pitcher; James L Henry
Journal:  Exp Neurol       Date:  2008-08-16       Impact factor: 5.330

6.  Transition to persistent orofacial pain after nerve injury involves supraspinal serotonin mechanisms.

Authors:  Masamichi Okubo; Alberto Castro; Wei Guo; Shiping Zou; Ke Ren; Feng Wei; Asaf Keller; Ronald Dubner
Journal:  J Neurosci       Date:  2013-03-20       Impact factor: 6.167

Review 7.  Exaggerated exercise pressor reflex in type 2 diabetes: Potential role of oxidative stress.

Authors:  Ann-Katrin Grotle; Audrey J Stone
Journal:  Auton Neurosci       Date:  2019-10-21       Impact factor: 3.145

8.  Cutaneous allodynia in the migraine population.

Authors:  Richard B Lipton; Marcelo E Bigal; Sait Ashina; Rami Burstein; Stephen Silberstein; Michael L Reed; Daniel Serrano; Walter F Stewart
Journal:  Ann Neurol       Date:  2008-02       Impact factor: 10.422

9.  Intact cutaneous C fibre afferent properties in mechanical and cold neuropathic allodynia.

Authors:  Richard Hulse; David Wynick; Lucy F Donaldson
Journal:  Eur J Pain       Date:  2009-11-25       Impact factor: 3.931

10.  Bilateral elevation of interleukin-6 protein and mRNA in both lumbar and cervical dorsal root ganglia following unilateral chronic compression injury of the sciatic nerve.

Authors:  Petr Dubový; Václav Brázda; Ilona Klusáková; Ivana Hradilová-Svíženská
Journal:  J Neuroinflammation       Date:  2013-05-01       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.